Puma Biotechnology Inc (NASDAQ:PBYI)
| 4.04 BATS BZX Real-Time Price As of 10:43am ET |  -0.06 / -1.46%Today’s Change | 2.13 Today|||52-Week Range 5.16 | -4.49% Year-to-Date |
Latest PBYI News | Press Releases
Today’s Trading
| Previous close | 4.10 |
| Today’s open | 4.20 |
| Day’s range | 3.82 - 4.20 |
| Volume | 6,056 |
| Average volume (3 months) | 165,730 |
| Market cap | $213.6M |
Data as of 10:43am ET, 11/29/2023
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +6.13% |
| Revenue growth (last year) | -9.92% |
| P/E ratio | 57.7 |
| Price/Sales | 0.83 |
| Price/Book | 8.27 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SCPHscPharmaceuticals In... | +0.16 | +2.95% |
| IPHAInnate Pharma SA | 0.00 | 0.00% |
| ENTAEnanta Pharmaceutica... | +0.49 | +5.05% |
| VNDAVanda Pharmaceutical... | +0.15 | +4.08% |
Data as of 10:57am ET, 11/29/2023
Financials
| Next reporting date | February 29, 2024 |
| EPS forecast (this quarter) | $0.22 |
| Annual revenue (last year) | $228.0M |
| Annual profit (last year) | $2.0K |
| Net profit margin | 0.00% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Los Angeles, California |
Forecasts
